Sankalp Gokhale
Technik-/Wissenschafts-/F&E-Leiter bei DIANTHUS THERAPEUTICS, INC.
Aktive Positionen von Sankalp Gokhale
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.09.2023 | - |
Karriereverlauf von Sankalp Gokhale
Ehemalige bekannte Positionen von Sankalp Gokhale
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
RADIUS HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Sankalp Gokhale
University of Arizona | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Sankalp Gokhale
- Erfahrung